JSE lifts on optimism about possible vaccine for Covid-19

The JSE was firmer on Tuesday, along with its global counterparts as optimism over a possible coronavirus vaccine is lifting sentiment, with investors looking past simmering US-China trade tension.

On Monday, US biotech firm Novavax said that it has started the first human study of its experimental coronavirus vaccine. The firm said it expects initial results on safety and immune responses in July.